overall sales volume, the Company and its subsidiaries brought 1.6% growth of Gross profit margin versus 2017 by the strong contribution of Epicerol® business. 2. In 2018, distribution costs, administrative

mm Unless otherwise stated 12 months ended Dec. 31 2018 2017 Total sales 871.09 723.96 Cost of Sales 288.97 244.33 Gross Profit 582.12 479.63 Gross Profit Margin (%) 66.83 66.25 For 12-month of 2018

13.77 million or 4.08% from the same period of last year. Such decrease was in line with a decrease in sales volume. Gross Profit Margin Gross profit margin was 32.14% in 2Q19, which declined from the

or 0.6%, but gross profit margin from sale of goods was at the same level of 44.2% compared with the same period last year. Gross profit amount and margin from sale of goods for the three-month period

-o- y) from Bt305.6 million in Q1/2017, representing a Net profit margin of 35.3% compared to 34.4% which has an earnings per share of Bt0.51. Table summarized the operating results of the Group (unit

% Rental Revenue 1,118.2 1,025.3 (92.9) (8.3%) Gross Profit 672.9 485.8 (187.2) (27.8%) Gross Profit Margin 60.2% 47.4% GPM before adjustment with PPA 61.1% 47.9% Revenue from Sale of Investment Properties

(82.6%) (73.8%) 45.3 110.9 144.8% 4 Gross Profit and Gross Profit Margin for the period ended 30 June 2024 and 2023 are presented below: Gross Profit increase 13.8% QoQ from Baht 350.0 million to Baht

32% EBITDA 96 135 41% 177 248 40% Net Profit (Loss) for the Company 43 73 70% 77 127 65% Gross Profit Margin (%) 64.2% 66.5% 2.3% 64.1% 66.5% 2.4% EBITDA Margin1 (%) 31.8% 35.5% 3.7% 31.1% 34.3% 3.2

48.3% from 9M/2018, mainly due to the increase in both revenue from sale of goods and revenue from rental and rendering of services, higher gross profit margin from sale of goods, decreased percentage of

1.10 (33.77) -96.86% Other comprehensive income for the period - - - N/A - - - N/A Total comprehensive income for the period 13.64 (0.83) (14.47) -106.11% 34.87 1.10 (33.77) -96.86% Gross profit margin